A carregar...
Optimizing checkpoint inhibitors therapy for relapsed or progressive classic Hodgkin lymphoma by multiplex immunohistochemistry of the tumor microenvironment
Immune checkpoint‐blocking antibodies have therapeutic activity against relapsed or progressive classic Hodgkin lymphoma (cHL), but Hodgkin Reed‐Sternberg cells can develop resistance to this therapy via multiple mechanisms. To improve the efficacy of immune checkpoint blockade, we need a more preci...
Na minha lista:
| Publicado no: | Cancer Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558469/ https://ncbi.nlm.nih.gov/pubmed/31070022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2168 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|